Activity- and schedule-dependent interactions of paclitaxel, etoposide and hydroperoxy-ifosfamide in cisplatin-sensitive and -refractory human ovarian carcinoma cell lines.

por Klaassen, U., Harstrick, A., Schleucher, N., Vanhoefer, U., Schröder, J., Wilke, H., Seeber, S.
Publicado 1996

Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines

por Vanhoefer, U, Müller, M R, Hilger, R A, Lindtner, B, Klaassen, U, Schleucher, N, Rustum, Y M, Seeber, S
Publicado 1999